Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Price-to-Tangible-Book : 0.00 (As of Jun. 20, 2024)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-06-20), Skystar Bio-Pharmaceutical Co's share price is $1.0E-5. Skystar Bio-Pharmaceutical Co's Tangible Book per Share of Sep. 2014 for the quarter that ended in Sep. 2014 was $13.82. Hence, Skystar Bio-Pharmaceutical Co's Price to Tangible Book Ratio of today is 0.00.

The historical rank and industry rank for Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

SKBI's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.3
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Skystar Bio-Pharmaceutical Co's share price is $1.0E-5. Skystar Bio-Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Sep. 2014 was $14.41. Hence, Skystar Bio-Pharmaceutical Co's P/B Ratio of today is 0.00.

Skystar Bio-Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Price-to-Tangible-Book Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.36

1.06

0.24

0.13

0.25

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.44	0.25	0.47	0.51	0.30

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book falls into.

Skystar Bio-Pharmaceutical Co Price-to-Tangible-Book Calculation

Skystar Bio-Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2014 )
	=	1.0E-5	/	13.824
	=	0.00

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Skystar Bio-Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines